• OPEN AN ACCOUNT
Indian Indices
Nifty
24,750.70 -82.90
(-0.33%)
Sensex
81,451.01 -182.01
( -0.22%)
Bank Nifty
55,749.70 203.65
( 0.37%)
Nifty IT
37,321.75 -432.40
( -1.15%)
Global Indices
Nasdaq
42,280.67 43.94
(0.10%)
Dow Jones
5,931.28 -1.89
(-0.03%)
Hang Seng
38,097.61 -335.37
(-0.87%)
Nikkei 225
8,772.38 55.93
(0.64%)
Forex
USD-INR
85.50 0.07
(0.09%)
EUR-INR
97.01 0.42
(0.44%)
GBP-INR
115.18 0.03
(0.03%)
JPY-INR
0.59 0.00
(0.53%)

EQUITY - MARKET SCREENER

Cohance Lifesciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543064
INE03QK01018
90.9609293
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
COHANCE
97.91
26595.67
EPS(TTM)
Face Value()
Div & Yield %
10.67
1
0
 

As on: May 30, 2025 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
1,044.75 -21.85 7400 97.91
Stock Price Details
Open Price() 1,099.80
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 1,099.80
Today's Low () 1,031.95
52-Week High () 1359
152-Week Low () 597
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.00
Eps 10.67
Book Value 90.9609293
Market Cap (.Cr) 26,595.67
Face Value 1
Market Lot 1
AGM Date Aug
Book Closure Date
ISIN No. INE03QK01018


News
Cohance Lifesciences consolidated net profit declines 21.29% in the March 2025 quarter
Cohance Lifesciences Ltd - Cohance Lifesciences Limited - Investor Presentation
Cohance Lifesciences Ltd - Cohance Lifesciences Limited - Credit Rating
Cohance Lifesciences Ltd - Cohance Lifesciences Limited - Outcome of Board Meeting
Cohance Lifesciences' API Unit-IV clears USFDA inspection
Cohance Lifesciences Ltd - Cohance Lifesciences Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Suven Pharmaceuticals Ltd - Cohance Lifesciences Limited - Analysts/Institutional Investor Meet/Con. Call Updates
Suven Pharmaceuticals Ltd - Suven Pharmaceuticals Limited - Updates
Sun Pharmaceutical Industries Ltd Slips 5.32%
Suven Pharmaceuticals Ltd - Suven Pharmaceuticals Limited - Disclosure under SEBI Takeover Regulations
More
Corporate Details
Incoporation Year   : 2018
Chairman : VIVEK SHARMA
Bussiness Group : Indian Private
Registered Office
Cohance Lifesciences Ltd
8-2-334 SDE Serene Chambers,
3 Floor Avenue 7 Road No 5,
Hyderabad,
Telangana-500034
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-40-23549414/1142/3311
Fax:91-40-23541152
Fax:91-22-66317458
E-Mail : khrao@suvenpharm.com
URL : http://www.suvenpharm.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE HC
  • BSE SmallCap
  • CNX 500
  • CNX MNC
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi